• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS SANTA CLARA MYNXGRIP VASCULAR CLOSURE DEVICE 5F; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS SANTA CLARA MYNXGRIP VASCULAR CLOSURE DEVICE 5F; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number MX5021
Device Problem Separation Failure (2547)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/06/2019
Event Type  malfunction  
Manufacturer Narrative
As reported, it was noted that approximately ¼ of the sealant was still at the end of the hypo tube, upon removal of the 5f mynxgrip vascular closure device (vcd).Hemostasis was achieved with the remaining ¾ of the sealant and manual compression for thirty minutes or less.There was no reported patient injury.The device storage temperature did not exceed 25 °c.The user was trained on the use of the mynx device.The intended procedure was a diagnostic peripheral.The femoral artery¿s suitability was verified on angiography or venography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel type was a femoral arterial and was 7mm in size.There was no presence of peripheral vascular disease (pvd) / calcium in the vicinity of the puncture site, however, there was little vessel tortuosity.The sheath used in conjunction with the mynx was a 5f.There was no excess force applied during insertion.The balloon was fully deflated after shuttling down.The patient was neither hospitalized nor was the patient's hospitalization extended as a result of the event.The patient is noted to have recovered.The device was not returned for analysis as it was discarded.A product history record (phr) review of lot f1834401 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿sealant stuck to device components¿ could not be confirmed as the device was not returned for analysis.The exact cause of the issue reported could not be determined.Based on the limited information available for review, handling factors during device removal may have contributed to the sealant stuck to the advancer tube after removal.According to the mynxgrip instructions for use (ifu), which is not intended as a mitigation, remove device, it instructs users to ensure complete balloon deflation, then slowly withdraw the balloon catheter through the advancer tube lumen.Failure to hold the advancer tube in place and/or a proper position of the tamping tube was not maintained during catheter removal, part of the sealant could be dislodged, resulting in the reported incident.Neither the phr, nor the information available for review suggests a design or manufacturing related cause for the reported event.Therefore, no corrective/preventive action will be taken at this time.
 
Event Description
As reported, it was noted that approximately ¼ of the sealant was still at the end of the hypo tube, upon removal of the 5f mynxgrip vascular closure device (vcd).Hemostasis was achieved with the remaining ¾ of the sealant and manual compression for thirty minutes or less.There was no reported patient injury.The device storage temperature did not exceed 25 °c.The user was trained on the use of the mynx device.The intended procedure was a diagnostic peripheral.The femoral artery¿s suitability was verified on angiography or venography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel type was a femoral arterial and was 7mm in size.There was no presence of peripheral vascular disease (pvd) / calcium in the vicinity of the puncture site, however, there was little vessel tortuosity.The sheath used in conjunction with the mynx was a 5f.There was no excess force applied during insertion.The balloon was fully deflated after shuttling down.The patient was neither hospitalized nor was the patient's hospitalization extended as a result of the event.The patient is noted to have recovered.The device will not be returned for evaluation as it was not saved by the site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNXGRIP VASCULAR CLOSURE DEVICE 5F
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, CA 95054
7863138372
MDR Report Key8378128
MDR Text Key137423449
Report Number3004939290-2019-01058
Device Sequence Number1
Product Code MGB
UDI-Device Identifier10862028000403
UDI-Public(01)10862028000403(17)201231(10)F1834401
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Model NumberMX5021
Device Catalogue NumberMX5021
Device Lot NumberF1834401
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/07/2019
Initial Date FDA Received02/28/2019
Date Device Manufactured12/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN 5F SHEATH
-
-